Evidence map›Paper›PMID 30136449›Full record

ReviewDiabetes & metabolism journal2018

Diagnosing Diabetic Neuropathy: Something Old, Something New.

Ioannis N Petropoulos, Georgios Ponirakis, Adnan Khan, Hamad Almuhannadi, Hoda Gad, Rayaz A Malik

Registry-linked trialAbstract readReview
In one paragraph

Review in Diabetes & metabolism journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05247840 (INvesTigation the Abnormality of Detrusor ConTractility by Uroflowmetry in Diabetic Children), which is not on this map. Cited by 71 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05247840 not yet recruitingnot on this mapstarted 2022, after this paper: background citation

INvesTigation the Abnormality of Detrusor ConTractility by Uroflowmetry in Diabetic Children (INTACT Trial) - a Prospective, Cross-sectional, Observational, Controlled Study

TypeobservationalSponsorHeim Pal Children's HospitalRan2022 to 2027Enrolled350ConditionsDiabetes MellitusArmsuroflowmetry, Cardiovascular autonomic dysfunction test proposed by Ewing et al., peripheral nerve conduction test
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. The Role of Novel Biomarkers in the Early Management of Peripheral Diabetic Neuropathy.Central nervous system agents in medicinal chemistry · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ioannis N PetropoulosDivision of Research, Weill Cornell Medicine Qatar, Doha, Qatar.
Georgios PonirakisDivision of Research, Weill Cornell Medicine Qatar, Doha, Qatar.
Adnan KhanDivision of Research, Weill Cornell Medicine Qatar, Doha, Qatar.
Hamad AlmuhannadiDivision of Research, Weill Cornell Medicine Qatar, Doha, Qatar.
Hoda GadDivision of Research, Weill Cornell Medicine Qatar, Doha, Qatar.
Rayaz A MalikDivision of Research, Weill Cornell Medicine Qatar, Doha, Qatar. ram2045@qatar-med.cornell.edu.ORCID https://orcid.org/0000-0002-7188-8903

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are potentially many ways of assessing diabetic peripheral neuropathy (DPN). However, they do not fulfill U.S. Food and Drug Administration (FDA) requirements in relation to their capacity to assess therapeutic benefit in clinical trials of DPN. Over the past several decades symptoms and signs, quantitative sensory and electrodiagnostic testing have been strongly endorsed, but have consistently failed as surrogate end points in clinical trials. Therefore, there is an unmet need for reliable biomarkers to capture the onset and progression and to facilitate drug discovery in DPN. Corneal confocal microscopy (CCM) is a non-invasive ophthalmic imaging modality for

Indexed as

ComplicationsDiabetic neuropathiesDiagnosis

Identifiers

PMID30136449
PMCPMC6107364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.